495.50
0.00
(0.00%)
As of January 10 at 3:40:16 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 10 | 14 | 14 |
| Avg. Estimate | 1.84B | 1.87B | 7B | 7.65B |
| Low Estimate | 1.82B | 1.84B | 6.98B | 7.57B |
| High Estimate | 1.86B | 1.91B | 7.02B | 7.96B |
| Year Ago Sales | 1.61B | 1.68B | 6.18B | 7B |
| Sales Growth (year/est) | 13.86% | 11.33% | 13.30% | 9.34% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ROP.F | -- | -- | -- | -- |
| S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Upgrades & Downgrades
| Maintains | Barclays: Underweight to Underweight | 1/8/2025 |
| Downgrade | Barclays: Overweight to Underweight | 12/5/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 10/24/2024 |
| Reiterates | Truist Securities: Buy to Buy | 10/24/2024 |
| Maintains | Baird: Outperform to Outperform | 10/24/2024 |
| Maintains | Mizuho: Neutral to Neutral | 10/17/2024 |